Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028430 · ClinicalTrials.gov registry record
B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT01028430 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 1,000 participants.
The verdict
NCT01028430 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
B-CLL is the most prevalent leukemia in the Western hemisphere, accounting for \~25% of all leukemia's (1). This disease occurs virtually exclusively in the aging population, with the median age of diagnosis ranging between the mid 60s and the early 70s. Indeed, its occurrence before the age of 50 is quite unusual. This increase in occurrence with age is not unique to B-CLL; rather, it is characteristic several B cell lymphoproliferative disorders (e.g., non-Hodgkin's lymphoma, multiple myeloma). Gender and race also influence the development of B-CLL. Thus, the ratio of men: women is \~2:1 and the prevalence is increased in Caucasians. The rate of occurrence of B-CLL among Asians is significantly lower than for Caucasians and this does not increase with immigration to the West. DNA sequence analyses performed in our laboratory and in those of others indicate that B-CLL cells from unrelated patients share Ig V gene characteristics. These include the use of selected genes, the association of these genes with certain D and JH gene segments that code for unique CDR3 motifs, and the occasional occurrence of highly similar VHDJH + VLJL pairs. In \~50% cases, these rearranged genes are mutated, whereas in the others mutations are infrequent; this difference is related to the VH gene family used by the B-CLL cell.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 1998-07 |
| Est. Completion | 2023-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028430
The ClinicalTrials.gov registry entry for NCT01028430 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01028430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028430 about?
NCT01028430 is a clinical study titled "B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging". B-CLL is the most prevalent leukemia in the Western hemisphere, accounting for \~25% of all leukemia's (1). This disease occurs virtually exclusively in the aging population, with the median age of diagnosis ranging between the mid 60s and the early 70s. Indeed, its occurrence before the age of 50 i...
What is the current status of trial NCT01028430?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 1998-07. Estimated completion is 2023-09.
Who is sponsoring clinical trial NCT01028430?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.